The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

Recent Market Growth

• Steady Expansion: The urolithiasis management devices market grew from $1.49 billion in 2023 to $1.59 billion in 2024, reflecting a 6.4% CAGR.
• Historical Growth Drivers: The market has benefited from increased healthcare spending, a growing aging population leading to a higher incidence of urolithiasis, expansion of healthcare infrastructure, and regulatory approvals that have ensured the safety and efficacy of treatments.

Future Market Projections

• Continued Growth: The market is projected to reach $2.05 billion by 2028, with a CAGR of 6.6%.
• Key Growth Factors: The increasing awareness of minimally invasive procedures, the rising incidence and recurrence of urolithiasis, continued advancements in endoscopic procedures, a shift towards outpatient treatments, and a growing patient preference for non-invasive treatment options are expected to drive the market.

Impact of Kidney Disease Prevalence on Market Growth

• Rising Kidney Disease Incidence: The increasing prevalence of kidney diseases, fueled by factors such as high animal protein consumption, sedentary lifestyles, and rising obesity rates, is a significant driver of the urolithiasis management devices market.
• Market Implications: These devices are crucial for healthcare professionals to perform precise interventions, relieve obstructions, prevent complications, and improve patient outcomes in cases of urolithiasis-related kidney issues.
• Example: According to Kidney Research UK, the incidence of acute kidney injury is projected to increase from 615,000 episodes in 2022 to 637,000 by 2033.

View More On The Urolithiasis Management Devices Market Report 2024 –
https://www.thebusinessresearchcompany.com/report/urolithiasis-management-devices-global-market-report

Technological Innovations in Urolithiasis Management Devices

• Thulium Fiber Laser (TFL) Technology: Companies are focusing on developing innovative products like TFL technology-based laser machines for enhanced treatment of urolithiasis.
• Product Launch: In July 2023, Coloplast AS introduced the Coloplast TFL Drive, a cutting-edge thulium fiber laser system designed for lithotripsy and precise soft tissue procedures, offering faster and safer treatments.

Strategic Acquisitions in the Market

• Boston Scientific and Lumenis Acquisition: In September 2021, Boston Scientific Corporation acquired Lumenis Ltd., aiming to enhance its urology and pelvic health portfolio. This acquisition strengthens Boston Scientific’s ability to offer minimally invasive solutions, leveraging Lumenis’s expertise in urolithiasis management devices.

Market Segmentation

• By Product Type: The market is segmented into lithotripters and ureteroscopes.
• By Treatment Type: Key treatment types include extracorporeal shock wave lithotripsy (ESWL), intracorporeal lithotripsy, percutaneous nephrolithotomy, and other treatments.
• By End-User: The primary end-users are hospitals, clinics, and ambulatory surgical centers.

Regional Insights

• North America: The largest region in the urolithiasis management devices market in 2023, driven by advanced healthcare infrastructure and a high prevalence of kidney diseases.
• Asia-Pacific: Expected to be the fastest-growing region during the forecast period, fueled by increasing healthcare investments and rising awareness of urological health.

Conclusion
The urolithiasis management devices market is set for strong growth, driven by technological innovations, rising kidney disease prevalence, and strategic acquisitions. With a growing focus on patient comfort, safety, and minimally invasive procedures, the market will continue to expand, providing opportunities for further advancements and improved patient care.

Request A Sample Of The Global Urolithiasis Management Devices Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=15691&type=smp